Chihiro Tomoyasu - Concepedia

Author

Chihiro Tomoyasu

Also Known As

Chihiro Tomoyasu

Publications

130

Citations

H-Index

Concepts

All Affiliations

Chihiro Tomoyasu is an author at Kyoto Prefectural University of Medicine specializing in medicine, cell biology, and hematology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	84
2	Cell Biology	3	3	84
3	Immunology	2	2	69
4	Health Sciences	1	1	15
5	Molecular Genetics	1	1	15

Chihiro Tomoyasu

Publications

107

Citations

H-Index

Page 1

	Year	Citations
Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines Kazuya Takahashi, Takeshi Inukai, Toshihiko Imamura, PLoS ONE Mixed-phenotype Acute LeukemiaApoptosisImmunologyCell DeathRefractory All	2017	44
BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression? Sachiko Kawashima‐Goto, Toshihiko Imamura, Chihiro Tomoyasu, PLoS ONE Bcl2 InhibitorPsl ResistanceHematological MalignancyHigh Mef2c ExpressionPrednisolone Sensitivity	2015	25
Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes Chihiro Tomoyasu, Toshihiko Imamura, Toshihiro Tomii, International Journal of Hematology Hematological MalignancyGenetic SubtypesTumor HeterogeneityMedicineGenetics	2018	15
OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells Chihiro Tomoyasu, Ken Kikuchi, Daisuke Kaneda, Oncology Reports	2018	12
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of <i>NOXA</i> Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, Molecular Cancer Therapeutics	2020	11

Page 1